Table 2 Respiratory evolution at 4 years of age after admission for bronchiolitis (N = 248)
From: Nasal TSLP and periostin in infants with severe bronchiolitis and risk of asthma at 4 years of age
Clinical features | (N, %) |
|---|---|
Recurrent wheezing | 181 (73%) |
Recurrent wheezing in the last 12 months | 93 (37%) |
Emergency care attendance for wheezing | 126 (51%) |
Emergency care attendance for wheezing in the last 12 months | 49 (20%) |
Admission for wheezing episode | 49 (20%) |
Admission for wheezing episode in the last 12 months | 12 (5%) |
Acute oral corticosteroid treatment | 112 (45%) |
Acute oral corticosteroid treatment in the last 12 months | 43 (17%) |
Chronic asthma treatment prescription | 94 (38%) |
Chronic asthma treatment prescription in the last 12 months | 35 (14%) |
Montelukast treatment | 38 (15%) |
Inhaled glucocorticoid treatment | 56 (22.5%) |
Montelukast + Inhaled glucocorticoid treatment | 28 (11%) |
Inhaled glucocorticoid + long beta 2 agonist treatment | 4 (1.6%) |
ISAAC—asthma questionnaire | |
Question 1. Ever wheezing in the chest at any time in the past | 197(79%) |
Question 2. Wheezing in the chest in the last 12 months (“Current asthma”) | 92 (37%) |
Question 5. In the last 12 months, wheezing severe enough to limit speech | 10 (4%) |
Question 6. Ever asthma | 53(21%) |
Question 7. In the last 12 months, chest sounded wheezy during or after exercise | 27 (11%) |
Question 8. In the last 12 months, dry cough at night, apart from a cough associated with a cold or a chest infection | 35 (14%) |